Search

Your search keyword '"Cho, Hee‐Jin"' showing total 438 results

Search Constraints

Start Over You searched for: Author "Cho, Hee‐Jin" Remove constraint Author: "Cho, Hee‐Jin"
438 results on '"Cho, Hee‐Jin"'

Search Results

3. Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma

5. Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling

7. Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study

9. Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial

10. The Rationalization of Korean Universities

14. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

16. The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling

17. Identifying predictors of glioma evolution from longitudinal sequencing

21. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma

22. Neck Pain Disability on Headache Impact and the Association between Sleep Disturbance and Neck Pain in Migraine

23. Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

24. Abstract CT038: Comprehensive molecular characterization of clinical response to durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: A phase 2 clinical trial

30. Data from Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling

31. Supplementary Figure 1-3 from Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling

33. Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

34. Comprehensive pharmacogenomic characterization of gastric cancer

35. Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers

37. Graphene-Based Composite Materials for Chemical Sensor Application

38. Phase II Trial with Correlative Genomic Analysis of Durvalumab Plus Pazopanib Combination in Patients with Advanced Soft Tissue Sarcomas

39. Additional file 2 of Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma

40. Additional file 3 of Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma

46. Recapitulated Crosstalk between Cerebral Metastatic Lung Cancer Cells and Brain Perivascular Tumor Microenvironment in a Microfluidic Co‐Culture Chip (Adv. Sci. 22/2022)

47. Characteristics of spinal and bulbar muscular atrophy in South Korea: a cross-sectional study of 157 patients.

Catalog

Books, media, physical & digital resources